Prudential Financial Inc Heron Therapeutics, Inc. Transaction History
Prudential Financial Inc
- $80 Billion
- Q3 2025
A detailed history of Prudential Financial Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 34,465 shares of HRTX stock, worth $39,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,465
Previous 36,465
5.48%
Holding current value
$39,290
Previous $75,000
41.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HRTX
# of Institutions
184Shares Held
132MCall Options Held
1.56MPut Options Held
27.1K-
Rubric Capital Management LP New York, NY26.7MShares$30.5 Million1.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.46MShares$9.64 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$9.49 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$8.95 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$7.96 Million24.86% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $135M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...